Prochlorperazine dimesylate is a phenothiazine derivative within the antipsychotic class of drugs, clinically indicated for the management of severe nausea and vomiting linked to conditions such as chemotherapy… Read more
Prochlorperazine dimesylate is a phenothiazine derivative within the antipsychotic class of drugs, clinically indicated for the management of severe nausea and vomiting linked to conditions such as chemotherapy or motion sickness. By acting as a dopamine receptor antagonist in the chemoreceptor trigger zone, the drug effectively suppresses emetic reflexes. To support the rigorous demands of pharmaceutical manufacturing, this selection provides critical reference materials including the parent drug API, pharmacopeial and non-pharmacopeial impurities, and stable isotope labelled compounds. These high-quality reference standards are essential tools for analytical testing, impurity profiling, and method validation. Laboratories rely on these substances to ensure accurate quantification and regulatory compliance during the quality control of Prochlorperazine dimesylate formulations, facilitating precise identification and monitoring of degradation products throughout the drug development lifecycle.